Fundraising Fox
/Companies
Sign in

Replicate Bioscience

San Diego, US · Founded 2021 · Delaware corporation · 23 employees on LinkedIn · 1 known investors

Find your way into Replicate Bioscience

575 people in our graph share verified history with the Replicate Bioscience team — schools, employers, funds. One of them is your warm intro.

Carol Lynchunlockedknows Andy Geall · together at Novartis Pharma AG (overlapped)
×8knows the team · via Novartis Pharma AG
knows the team · via Scripps Research
×2knows the team · via Syntheticgenomics

Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.

BiotechDeep TechHealthtech

Founders & leadership

Replicate Bioscience was founded in 2021 by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, and Zachary Hartman.

NWNathaniel Wang
Nathaniel WangChief Executive Officer and Co-FounderNathaniel Wang is co-founder of Replicate Bioscience and brings over 15 years of experience in immunology and drug development across biotech and pharma, with expertise in synthetic self-replicating RNA technologies and their applications in therapeutics. He has held leadership roles in business strategy, corporate development, and team management, and is the author of multiple scientific publications and patents in the field.
AGAndy Geall
Andy GeallCo-founderWith over 20 years of experience in mRNA vaccines and nucleic acid delivery, he has led research translation to clinical development, managed multidisciplinary teams, and scaled manufacturing processes to GMP standards.
HKHerbert Kim Lyerly
Herbert Kim LyerlyCo-founderCMO & Founder at Trio Pharmaceuticals
ZH
Zachary HartmanCo-founder
JY
Joseph YanchikNamed on SEC filingVenture Partner at Apple Tree Venture Management Llc

Board

SH
Seth HarrisonBoard directorFounder and Managing Partner at Apple Tree Venture Management Llc
ME
Michael EhlersCo-Founder and Board MemberVenture Partner at Apple Tree Venture Management Llc

Investors · 1

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2021

▶$20MraisedMar 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel WangExecutive Officer, Director
  • Seth HarrisonDirector
  • Joseph YanchikDirector
  • Michael EhlersExecutive Officer, Director
Offering amount
$53M
Amount sold
$20M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Life Biosciences4 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan

Companies competing with Replicate Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Replicate Bioscience do?
Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
Who founded Replicate Bioscience?
Replicate Bioscience was founded by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, Zachary Hartman in 2021.
Who are Replicate Bioscience's investors?
Replicate Bioscience's investors include ATP.
How much funding has Replicate Bioscience raised?
Replicate Bioscience has disclosed $20M raised across 1 round.
Where is Replicate Bioscience headquartered?
Replicate Bioscience is headquartered in San Diego, US.